Business
Why the Aroa Biosurgery (ASX:ARX) share price is lifting today
The Aroa Biosurgery Ltd (ASX: ARX) share price is up 2.6% after the company shared positive news this morning. A new product from the soft-tissue regeneration company has received US Food and Drug Administration (FDA) clearance.
At the time of writing, the Aroa Biosurgery share price is trading at $1.17 after reaching an intraday high of $1.22 this morning.
Let’s look closer at the news of Aroa Biosurgery’s newest FDA cleared product.
Myriad Morcells
The company’s new product, Myriad Morcells, works to “kick start” a wound’s healing, according to Aroa Biosurgery vice president of research and clinical development Dr Barnaby…
-
Noosa News21 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General21 hours agoMinjee Lee rallies after third-round meltdown to share fifth place at LA Championship
-
General15 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General14 hours agoPope Francis appears Easter Sunday to deliver blessing as recovery continues